The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Ward Keith Wayne since year 2005.
The trader's CIK number is 1662394.
At the time of this reporting, Ward Keith Wayne is the Chief Development Officer of Reata Pharmaceuticals Inc .
(stock ticker symbol RETA).
See this page for all insider trading activities at Reata Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-02-26||RETA||Reata Pharmaceuticals Inc||Sale||25,184||91.31||2,299,551|
|2019-02-25||RETA||Reata Pharmaceuticals Inc||Sale||15,183||91.00||1,381,653|
|2019-01-31||RETA||Reata Pharmaceuticals Inc||Sale||4,150||76.57||317,765|
|2019-01-02||RETA||Reata Pharmaceuticals Inc||Sale||4,150||54.15||224,701|
|2018-11-07||RETA||Reata Pharmaceuticals Inc||Sale||4,750||67.39||320,078|
|2018-11-01||RETA||Reata Pharmaceuticals Inc||Sale||4,750||59.48||282,530|
|2018-10-23||RETA||Reata Pharmaceuticals Inc||Sale||14,250||57.08||813,390|
|2018-07-05||RETA||Reata Pharmaceuticals Inc||Sale||4,750||36.62||173,945|
|2018-06-05||RETA||Reata Pharmaceuticals Inc||Sale||28,500||36.62||1,043,669|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ward Keith Wayne (Chief Development Officer of Reata Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.